Rare diseases
Investigational molecules
Locations
Back to Italy1 231 clinical trials in Pozzuoli, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Elafibranor for Adults with Primary Biliary Cholangitis
ItalyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
ItalyStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
ItalyStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
ItalyStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
ItalyStudy on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction
ItalyStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
ItalyStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
ItalyStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
ItalyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
ItalyStudy of Tersolisib and a drug combination for adults with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Località la Schiana, Pozzuoli is strongly focused on cancer research, with studies examining how to improve treatment options for several advanced solid tumors. The main goal is to test new therapeutic strategies and refine existing combinations for better disease control and patient outcomes.
These studies are exploring more effective ways to slow progression, overcome treatment resistance, and improve survival in patients with advanced neoplasms.
Several trials in this site concentrate on digestive system cancers, especially advanced colorectal cancer. Research is centered on evaluating treatment effectiveness and finding better options for patients whose disease has already progressed or carries specific genetic changes.
Across these studies, the focus is on improving tumor response, extending disease control, and identifying which patients may benefit most from targeted treatment approaches.
This research landscape also includes therapeutic techniques aimed at improving how treatments are delivered and how response is monitored. The trials are not only testing active therapies, but also looking for better ways to understand resistance, safety, and treatment benefit in real-world patients.
In this part of the research portfolio, investigators in Pozzuoli are helping shape more precise and patient-centered cancer care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
